JP2025500321A5 - - Google Patents
Info
- Publication number
- JP2025500321A5 JP2025500321A5 JP2024537118A JP2024537118A JP2025500321A5 JP 2025500321 A5 JP2025500321 A5 JP 2025500321A5 JP 2024537118 A JP2024537118 A JP 2024537118A JP 2024537118 A JP2024537118 A JP 2024537118A JP 2025500321 A5 JP2025500321 A5 JP 2025500321A5
- Authority
- JP
- Japan
- Prior art keywords
- independently selected
- optionally substituted
- compound according
- occurrence
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163293730P | 2021-12-24 | 2021-12-24 | |
| US63/293,730 | 2021-12-24 | ||
| US202263299817P | 2022-01-14 | 2022-01-14 | |
| US63/299,817 | 2022-01-14 | ||
| US202263338994P | 2022-05-06 | 2022-05-06 | |
| US63/338,994 | 2022-05-06 | ||
| PCT/US2022/053910 WO2023122320A1 (en) | 2021-12-24 | 2022-12-23 | Polypodal serotonergic compounds and prodrugs of serotonin receptor agonists and antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500321A JP2025500321A (ja) | 2025-01-09 |
| JP2025500321A5 true JP2025500321A5 (https=) | 2026-01-06 |
Family
ID=86903690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537118A Pending JP2025500321A (ja) | 2021-12-24 | 2022-12-23 | 多脚型セロトニン作動性化合物ならびにセロトニン受容体アゴニスト及びアンタゴニストのプロドラッグ |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4452939A4 (https=) |
| JP (1) | JP2025500321A (https=) |
| WO (1) | WO2023122320A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023168023A1 (en) | 2022-03-04 | 2023-09-07 | Reset Pharmaceuticals, Inc. | Co-crystals or salts comprising psilocin |
| AU2023319280A1 (en) * | 2022-08-05 | 2025-03-20 | Mindset Pharma Inc. | 3-ethylamino-indole dimers as serotonergic agents useful for the treatment of disorders related thereto |
| WO2024081961A2 (en) * | 2022-10-14 | 2024-04-18 | Invyxis, Inc. | Ester analogs of psilocin, processes for the preparation thereof, and methods of use |
| WO2025045773A1 (en) * | 2023-08-25 | 2025-03-06 | Compass Pathfinder Limited | 3-(2-(dimethylamino)ethyl)-1h-indol-4-yl oligomeric derivatives |
| WO2025122513A1 (en) * | 2023-12-04 | 2025-06-12 | Delix Therapeutics, Inc. | Methods of treating neuropsychiatric disorders with non-hallucinogenic tryptamines |
| US20260021070A1 (en) * | 2024-07-19 | 2026-01-22 | Compass Pathfinder Limited | Subcutaneous formulations comprising psilocybin derivatives |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2731223A1 (fr) * | 1995-03-02 | 1996-09-06 | Pf Medicament | Nouveaux derives bi-tryptaminiques, leur procede de preparation et leur utilisation a titre de medicaments |
| EP2771341A4 (en) * | 2011-10-28 | 2015-09-23 | Univ Texas | NEW COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER |
| JP2016521683A (ja) * | 2013-05-24 | 2016-07-25 | ネステク ソシエテ アノニム | 過敏性腸症候群の診断を予測するための経路特異的なアッセイ |
| CA3052974A1 (en) * | 2017-02-09 | 2018-08-16 | CaaMTech, LLC | Compositions and methods comprising a psilocybin derivative |
| BR112022015379A2 (pt) * | 2020-02-04 | 2022-09-27 | Mindset Pharma Inc | Derivados de 3-pirrolidino-indol como agentes psicodélicos serotonérgicos para o tratamento de distúrbios do snc |
| CA3188636A1 (en) * | 2020-08-21 | 2022-02-24 | Matthias GRILL | Novel psilocin derivatives having prodrug properties |
| AU2023234202A1 (en) * | 2022-03-18 | 2024-11-07 | Enveric Biosciences Canada Inc. | Salts of c4-carboxylic acid- and c4-carbonothioate-substituted tryptamine derivatives and methods of using |
| AU2023319280A1 (en) * | 2022-08-05 | 2025-03-20 | Mindset Pharma Inc. | 3-ethylamino-indole dimers as serotonergic agents useful for the treatment of disorders related thereto |
| CN120091999A (zh) * | 2022-08-05 | 2025-06-03 | 思维模式制药公司 | 作为血清素能剂用于治疗相关病症的3-吡咯烷-吲哚二聚体 |
| WO2024081961A2 (en) * | 2022-10-14 | 2024-04-18 | Invyxis, Inc. | Ester analogs of psilocin, processes for the preparation thereof, and methods of use |
-
2022
- 2022-12-23 EP EP22912515.8A patent/EP4452939A4/en active Pending
- 2022-12-23 JP JP2024537118A patent/JP2025500321A/ja active Pending
- 2022-12-23 WO PCT/US2022/053910 patent/WO2023122320A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025500321A5 (https=) | ||
| JP2024531229A5 (https=) | ||
| DK153940C (da) | Analogifremgangsmaade til fremstilling af 1-aryloxy-3-alkylamino-2-propanol-derivater eller farmaceutisk anvendelige, ugiftige syreadditionssalte deraf | |
| Lu et al. | Transition metal-free direct trifluoromethylthiolation of indoles using trifluoromethanesulfonyl chloride in the presence of triphenylphosphine | |
| JP2022545633A5 (https=) | ||
| JP2010528089A5 (https=) | ||
| JP2011016800A5 (https=) | ||
| IN2014CN00532A (https=) | ||
| JP2015532275A5 (https=) | ||
| CY1114932T1 (el) | Αντιπαρασιτικοι παραγοντες | |
| RU2009133453A (ru) | Фторсодержащее пиразолкарбонитрильное производное и способ его получения и фторсодержащее производное пиразолкарбоновой кислоты, полученное с применением фторсодержащего пиразолкарбонитрильного производного и способ его получения | |
| JPWO2022138968A5 (https=) | ||
| JP2023518776A5 (https=) | ||
| JP2025507292A5 (https=) | ||
| Feraldi‐Xypolia et al. | Synthesis of Functionalized 4‐Fluoropyridazines | |
| IL318795A (en) | 3-Ethylaminoindole dimers as serotonergic agents useful for the treatment of related disorders | |
| KR900006307A (ko) | 단백질 키나아제 c억제제로서 유용한 신규 퀴놀릴옥사졸-2-온 | |
| KR920009802A (ko) | 치환된 아졸, 이의 제조방법, 이를 함유하는 제제 및 이의 용도 | |
| JP2010235601A5 (https=) | ||
| Ryabov et al. | Structural and mechanistic look at the orthoplatination of aryl oximes by dichlorobis (sulfoxide or sulfide) platinum (II) complexes | |
| Li et al. | Transition-metal-free amination phosphoryl azide for the synthesis of phosphoramidates | |
| JP2018090537A5 (https=) | ||
| Erb et al. | Synthesis of Ferrocenesulfonyl Chloride: Key Intermediate toward Ferrocenesulfonamides | |
| IL318794A (en) | 3-Pyrrolidine Indole Dimers as Serotonergic Agents Useful for the Treatment of Related Disorders | |
| Zaguzin et al. | Strong halogen bonds with guest molecules in a Co (ii) 2, 5-diiodoterephthalate metal–organic framework |